MariMed Inc. (OTCMKTS:MRMD – Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 9,792 shares, an increase of 151.5% from the July 15th total of 3,893 shares. Based on an average daily volume of 433,915 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
MariMed Stock Performance
Shares of OTCMKTS:MRMD traded up $0.00 during midday trading on Friday, reaching $0.07. The company had a trading volume of 479,775 shares, compared to its average volume of 228,847. The stock has a market cap of $27.68 million, a P/E ratio of -1.73 and a beta of 1.33. The company’s 50 day moving average price is $0.07 and its 200 day moving average price is $0.08. The company has a current ratio of 0.95, a quick ratio of 0.34 and a debt-to-equity ratio of 1.67. MariMed has a 52-week low of $0.06 and a 52-week high of $0.23.
MariMed (OTCMKTS:MRMD – Get Free Report) last posted its quarterly earnings data on Wednesday, August 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). The business had revenue of $41.92 million during the quarter, compared to the consensus estimate of $39.80 million. MariMed had a negative net margin of 9.13% and a negative return on equity of 10.33%.
About MariMed
MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.
The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.
Further Reading
- Five stocks we like better than MariMed
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
